reference/27014264

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27014264

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	404
issn	1523-5866 1522-8517
issueIdentifier	3
pageRange	now189-404
publicationName	Neuro-Oncology
startingPage	now189
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eb4f340a1767b2ff28113b9d3c67834b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_748005ff899a0a44124f3fc0ddda15e3
bibliographicCitation	Nguyen HN, Lie A, Li T, Chowdhury R, Liu F, Ozer B, Wei B, Green RM, Ellingson BM, Wang HJ, Elashoff R, Liau LM, Yong WH, Nghiemphu PL, Cloughesy T, Lai A. Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy. Neuro Oncol. 2017 Mar 01;19(3):394–404. PMID: 27571882; PMCID: PMC5464302.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fdfdc1599e12625d9b7fb729fe1712f2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_42045ba8c28f3da55b341ea9fd9a47d8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c2e1d5b0b72c4070df2cec6d1945e77 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_448949d84fdc952c57a810e227300c72 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8056942d9bd4116c84146b712663318 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_19261a4d4f2cb9ba5b48a00737432ac4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4aecafe663eb7eff29e193eadf0c96bb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ac96ab909ca7e3d091bb736d87504ba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7c9582bafa8aab7e75718e9354ab90d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9754bb7601eef198b7a0da59ee22e9a8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6931973c379bbd64111fffd962f02d57 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3513db7477ec205400974e7d08f22d62 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b3fe3eee2d817df0702daddb3ad151ce http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_77cfaec5bcd5131e96af8c738393dde5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7323d8766763e07a01c7c275566be5d7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96d2ce6b1126ae9f670c89fd6a21bd54
date	2016-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1093/neuonc/now189 https://pubmed.ncbi.nlm.nih.gov/27571882 https://pubmed.ncbi.nlm.nih.gov/PMC5464302
isPartOf	https://portal.issn.org/resource/ISSN/1522-8517 https://portal.issn.org/resource/ISSN/1523-5866 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21645
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	HumanTERTpromoter mutation enables survival advantage fromMGMTpromoter methylation inIDH1wild-type primary glioblastoma treated by standard chemoradiotherapy
discusses	http://id.nlm.nih.gov/mesh/M0539173 http://id.nlm.nih.gov/mesh/M0448961 http://id.nlm.nih.gov/mesh/M0374857 http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0273402 http://id.nlm.nih.gov/mesh/M0023492 http://id.nlm.nih.gov/mesh/M0028508 http://id.nlm.nih.gov/mesh/M0011751 http://id.nlm.nih.gov/mesh/M0504746
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015254Q000235 http://id.nlm.nih.gov/mesh/D019175 http://id.nlm.nih.gov/mesh/D005909Q000401 http://id.nlm.nih.gov/mesh/D009154Q000235 http://id.nlm.nih.gov/mesh/D007521Q000235 http://id.nlm.nih.gov/mesh/D059248Q000401 http://id.nlm.nih.gov/mesh/D011401Q000235 http://id.nlm.nih.gov/mesh/D025521Q000235 http://id.nlm.nih.gov/mesh/D019098Q000235 http://id.nlm.nih.gov/mesh/D045643Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D001932Q000628 http://id.nlm.nih.gov/mesh/D005909Q000628 http://id.nlm.nih.gov/mesh/D001932Q000473 http://id.nlm.nih.gov/mesh/D060787 http://id.nlm.nih.gov/mesh/D005909Q000473 http://id.nlm.nih.gov/mesh/D005909Q000235 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D001932Q000235 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D009364Q000628 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D009364Q000473 http://id.nlm.nih.gov/mesh/D009364Q000401 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D001932Q000401 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D014408Q000235 http://id.nlm.nih.gov/mesh/D009364Q000235
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d724f231a9a7b89757c4394d6622bc47 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65275 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_281c3deab424c97785a96e0444a0943e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_165c3732382b3f59759560c5caf69bf8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7838

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7015

Total number of triples: 85.